The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue ...
Jan 13 (Reuters) - Global drugmakers are ramping up U.S. manufacturing and stockpiling inventory as the Trump administration considers imposing a 100% tariff on imported branded and patented medicines ...